Supernus Pharmaceuticals Inc (SUPN)
29.41
+0.53
(+1.84%)
USD |
NASDAQ |
Apr 19, 16:00
29.41
0.00 (0.00%)
After-Hours: 17:21
Supernus Pharmaceuticals Total Return Price: 29.41 for April 19, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 18, 2024 | 28.88 |
| April 17, 2024 | 29.00 |
| April 16, 2024 | 29.43 |
| April 15, 2024 | 29.99 |
| April 12, 2024 | 30.24 |
| April 11, 2024 | 32.00 |
| April 10, 2024 | 31.84 |
| April 09, 2024 | 31.73 |
| April 08, 2024 | 31.43 |
| April 05, 2024 | 33.55 |
| April 04, 2024 | 33.24 |
| April 03, 2024 | 33.85 |
| April 02, 2024 | 33.17 |
| April 01, 2024 | 33.52 |
| March 28, 2024 | 34.11 |
| March 27, 2024 | 33.74 |
| March 26, 2024 | 32.48 |
| March 25, 2024 | 32.75 |
| March 22, 2024 | 34.52 |
| March 21, 2024 | 35.17 |
| March 20, 2024 | 34.88 |
| March 19, 2024 | 35.15 |
| March 18, 2024 | 34.19 |
| March 15, 2024 | 32.98 |
| March 14, 2024 | 33.37 |
| Date | Value |
|---|---|
| March 13, 2024 | 34.66 |
| March 12, 2024 | 32.92 |
| March 11, 2024 | 32.43 |
| March 08, 2024 | 31.07 |
| March 07, 2024 | 30.81 |
| March 06, 2024 | 31.11 |
| March 05, 2024 | 30.35 |
| March 04, 2024 | 30.63 |
| March 01, 2024 | 31.01 |
| February 29, 2024 | 29.70 |
| February 28, 2024 | 31.08 |
| February 27, 2024 | 30.69 |
| February 26, 2024 | 29.50 |
| February 23, 2024 | 29.06 |
| February 22, 2024 | 27.94 |
| February 21, 2024 | 28.14 |
| February 20, 2024 | 28.05 |
| February 16, 2024 | 28.42 |
| February 15, 2024 | 28.66 |
| February 14, 2024 | 27.56 |
| February 13, 2024 | 27.11 |
| February 12, 2024 | 28.35 |
| February 09, 2024 | 27.91 |
| February 08, 2024 | 27.90 |
| February 07, 2024 | 27.24 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
14.45
Minimum
Mar 18 2020
42.03
Maximum
Feb 02 2023
28.82
Average
29.15
Median
Feb 18 2021
Total Return Price Benchmarks
| Dynavax Technologies Corp | 11.79 |
| Ligand Pharmaceuticals Inc | 72.55 |
| Pacira BioSciences Inc | 26.24 |
| Esperion Therapeutics Inc | 1.94 |
| Collegium Pharmaceutical Inc | 34.85 |